
Kenneth Jin Chang Lim, MBBS, discusses the failure of dexamethasone to reduce rates of neurotoxicity in myeloma with high ALC after CAR T-cell therapy.

Your AI-Trained Oncology Knowledge Connection!


Kenneth Jin Chang Lim, MBBS, is a hematology fellow at St Vincent’s Hospital Melbourne in Australia.

Kenneth Jin Chang Lim, MBBS, discusses the failure of dexamethasone to reduce rates of neurotoxicity in myeloma with high ALC after CAR T-cell therapy.